IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT

Authors
Category Primary study
JournalNeuro-Oncology
Year 2024
This article has no abstract
Epistemonikos ID: 3175a50464b79602f4dc6908c2e104befe9875c9
First added on: Feb 19, 2025